
CEP-28122 mesylate
CAS No. ——
CEP-28122 mesylate( —— )
Catalog No. M16991 CAS No. ——
A highly potent and selective, orally active ALK inhibitor with IC50 of 1.9 nM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
10MG | 185 | Get Quote |
![]() ![]() |
100MG | Get Quote | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameCEP-28122 mesylate
-
NoteResearch use only, not for human use.
-
Brief DescriptionA highly potent and selective, orally active ALK inhibitor with IC50 of 1.9 nM.
-
DescriptionA highly potent and selective, orally active ALK inhibitor with IC50 of 1.9 nM; exhibits no-to-weak inhibition against a panel of 259 kinases and only 15 kinases showes >90% inhibition at 1 uM; shows growth inhibition/cytotoxicity of ALCL, NSCLC, and neuroblastoma cells, and displays dose-dependent inhibition of ALK tyrosine phosphorylation in tumor xenografts in mice (30 mg/kg).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetALK
-
RecptorALK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight635.1746
-
Molecular FormulaC29H39ClN6O6S
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 6.4 mg/mL; DMSO < 9.2 mg/mL
-
SMILES——
-
Chemical NameBicyclo[2.2.1]hept-5-ene-2-carboxamide, 3-[[5-chloro-2-[[(7S)-6,7,8,9-tetrahydro-1-methoxy-7-(4-morpholinyl)-5H-benzocyclohepten-2-yl]amino]-4-pyrimidinyl]amino]-, (1S,2S,3R,4R)-, methanesulfonate (1:1)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Cheng M, et al. Mol Cancer Ther. 2012 Mar;11(3):670-9.
2. Sullivan I, et al. Ther Adv Med Oncol. 2016 Jan;8(1):32-47.
molnova catalog



related products
-
SB-505124 hydrochlor...
SB-505124 hydrochloride (SB505124 hydrochloride) is an orally available, selective and potent inhibitor of TGF-β type I receptors (ALK4, ALK5, ALK7) with IC50 values of 129 nM and 47 nM for ALK4 and ALK5, respectively.
-
Wy 49051
Wy 49051 is an orally active antagonist of H1 receptor(IC50 of 44 nM).
-
LDK378
Ceritinib is an orally available inhibitor of the receptor tyrosine kinase activity of anaplastic lymphoma kinase (ALK) with antineoplastic activity.